APA-viite

Kudo, T., Murai, Y., Kojima, Y., Uehara, K., & Satoh, T. (2020). Efficacy and safety of tolvaptan in patients with malignant ascites: A phase 2, multicenter, open-label, dose-escalation study. Jpn J Clin Oncol.

Chicago-tyylinen lähdeviittaus

Kudo, Toshihiro, Yoshiyuki Murai, Yoshitsugu Kojima, Kenji Uehara, ja Taroh Satoh. "Efficacy and Safety of Tolvaptan in Patients With Malignant Ascites: A Phase 2, Multicenter, Open-label, Dose-escalation Study." Jpn J Clin Oncol 2020.

MLA-viite

Kudo, Toshihiro, et al. "Efficacy and Safety of Tolvaptan in Patients With Malignant Ascites: A Phase 2, Multicenter, Open-label, Dose-escalation Study." Jpn J Clin Oncol 2020.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.